ADMA Biologics ADMA Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's interest coverage?
- ADMA Biologics (ADMA) reported interest coverage of 29.7× in Q1 2026.
- How has ADMA Biologics's interest coverage changed year-over-year?
- ADMA Biologics's interest coverage increased by 137.0% year-over-year, from 12.5× to 29.7×.
- What is the long-term trend for ADMA Biologics's interest coverage?
- Over 5 years (2020 to 2025), ADMA Biologics's interest coverage has grown at a 37.8% compound annual growth rate (CAGR), from -5.4× to 26.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.